599 related articles for article (PubMed ID: 34118007)
1. Impact of Remdesivir on the Treatment of COVID-19 During the First Wave in Spain.
Soriano A; Montejano R; Sanz-Moreno J; Figueira JC; Grau S; Güerri-Fernández R; Castro-Gómez A; Pérez-Román I; Hidalgo-Vega Á; González-Domínguez A
Adv Ther; 2021 Jul; 38(7):4057-4069. PubMed ID: 34118007
[TBL] [Abstract][Full Text] [Related]
2. Remdesivir and dexamethasone as tools to relieve hospital care systems stressed by COVID-19: A modelling study on bed resources and budget impact.
Béraud G; Timsit JF; Leleu H
PLoS One; 2022; 17(1):e0262462. PubMed ID: 35020746
[TBL] [Abstract][Full Text] [Related]
3. Retrospective modelling of hospital bed capacities associated with the administration of remdesivir during the first wave of COVID-19 in a German metropolitan city.
Jeck J; Jakobs F; Kron A; Cornely OA; Kron F
J Antimicrob Chemother; 2022 Feb; 77(3):753-757. PubMed ID: 34849943
[TBL] [Abstract][Full Text] [Related]
4. Remdesivir in combination with dexamethasone for patients hospitalized with COVID-19: A retrospective multicenter study.
Gressens SB; Esnault V; De Castro N; Sellier P; Sene D; Chantelot L; Hervier B; Delaugerre C; Chevret S; Molina JM;
PLoS One; 2022; 17(2):e0262564. PubMed ID: 35176057
[TBL] [Abstract][Full Text] [Related]
5. Remdesivir for the Treatment of Severe COVID-19: A Community Hospital's Experience.
Lee S; Santarelli A; Caine K; Schritter S; Dietrich T; Ashurst J
J Am Osteopath Assoc; 2020 Dec; 120(12):926-933. PubMed ID: 33136164
[TBL] [Abstract][Full Text] [Related]
6. Real-life use of remdesivir in hospitalized patients with COVID-19.
Garcia-Vidal C; Meira F; Cózar-Llistó A; Dueñas G; Puerta-Alcalde P; Garcia-Pouton N; Chumbita M; Cardozo C; Hernandez-Meneses M; Alonso-Navarro R; Rico V; Agüero D; Bodro M; Morata L; Jordan C; Lopera C; Ambrosioni J; Segui F; Grafia N; Castro P; García F; Mensa J; Martínez JA; Sanjuan G; Soriano A;
Rev Esp Quimioter; 2021 Apr; 34(2):136-140. PubMed ID: 33675220
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Time to Clinical Improvement With vs Without Remdesivir Treatment in Hospitalized Patients With COVID-19.
Garibaldi BT; Wang K; Robinson ML; Zeger SL; Bandeen-Roche K; Wang MC; Alexander GC; Gupta A; Bollinger R; Xu Y
JAMA Netw Open; 2021 Mar; 4(3):e213071. PubMed ID: 33760094
[TBL] [Abstract][Full Text] [Related]
8. Association of Remdesivir Treatment With Survival and Length of Hospital Stay Among US Veterans Hospitalized With COVID-19.
Ohl ME; Miller DR; Lund BC; Kobayashi T; Richardson Miell K; Beck BF; Alexander B; Crothers K; Vaughan Sarrazin MS
JAMA Netw Open; 2021 Jul; 4(7):e2114741. PubMed ID: 34264329
[TBL] [Abstract][Full Text] [Related]
9. Real-World Effectiveness of Remdesivir in Adults Hospitalized With Coronavirus Disease 2019 (COVID-19): A Retrospective, Multicenter Comparative Effectiveness Study.
Garibaldi BT; Wang K; Robinson ML; Betz J; Caleb Alexander G; Andersen KM; Joseph CS; Mehta HB; Korwek K; Sands KE; Fisher AM; Bollinger RC; Xu Y
Clin Infect Dis; 2022 Aug; 75(1):e516-e524. PubMed ID: 34910128
[TBL] [Abstract][Full Text] [Related]
10. Real-world outcomes of COVID-19 treatment with remdesivir in a Spanish hospital.
Hidalgo-Tenorio C; García-Vallecillos C; Sequera-Arquelladas S;
Medicine (Baltimore); 2021 Sep; 100(37):e27228. PubMed ID: 34664862
[TBL] [Abstract][Full Text] [Related]
11. Remdesivir, Renal Function and Short-Term Clinical Outcomes in Elderly COVID-19 Pneumonia Patients: A Single-Centre Study.
Biancalana E; Chiriacò M; Sciarrone P; Mengozzi A; Mechelli S; Taddei S; Solini A
Clin Interv Aging; 2021; 16():1037-1046. PubMed ID: 34113086
[TBL] [Abstract][Full Text] [Related]
12. Remdesivir for Severe Coronavirus Disease 2019 (COVID-19) Versus a Cohort Receiving Standard of Care.
Olender SA; Perez KK; Go AS; Balani B; Price-Haywood EG; Shah NS; Wang S; Walunas TL; Swaminathan S; Slim J; Chin B; De Wit S; Ali SM; Soriano Viladomiu A; Robinson P; Gottlieb RL; Tsang TYO; Lee IH; Hu H; Haubrich RH; Chokkalingam AP; Lin L; Zhong L; Bekele BN; Mera-Giler R; Phulpin C; Edgar H; Gallant J; Diaz-Cuervo H; Smith LE; Osinusi AO; Brainard DM; Bernardino JI;
Clin Infect Dis; 2021 Dec; 73(11):e4166-e4174. PubMed ID: 32706859
[TBL] [Abstract][Full Text] [Related]
13. Mortality in SARS-CoV-2 Hospitalized Patients Treated with Remdesivir: A Nationwide, Registry-Based Study in Italy.
Russo P; Tacconelli E; Olimpieri PP; Celant S; Colatrella A; Tomassini L; Palù G
Viruses; 2022 May; 14(6):. PubMed ID: 35746668
[TBL] [Abstract][Full Text] [Related]
14. Assessing efficacy of antiviral therapy for COVID-19 patients: A case study on remdesivir with bayesian synthesis design and multistate analysis.
Liao SH; Hung CC; Chen CN; Yen JY; Hsu CY; Yen AM; Chen CL
J Formos Med Assoc; 2021 Jun; 120 Suppl 1():S77-S85. PubMed ID: 34074579
[TBL] [Abstract][Full Text] [Related]
15. Remdesivir treatment in hospitalized patients affected by COVID-19 pneumonia: A case-control study.
Boglione L; Dodaro V; Meli G; Rostagno R; Poletti F; Moglia R; Bianchi B; Esposito M; Borrè S
J Med Virol; 2022 Aug; 94(8):3653-3660. PubMed ID: 35411627
[TBL] [Abstract][Full Text] [Related]
16. Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19: A Randomized Clinical Trial.
Spinner CD; Gottlieb RL; Criner GJ; Arribas López JR; Cattelan AM; Soriano Viladomiu A; Ogbuagu O; Malhotra P; Mullane KM; Castagna A; Chai LYA; Roestenberg M; Tsang OTY; Bernasconi E; Le Turnier P; Chang SC; SenGupta D; Hyland RH; Osinusi AO; Cao H; Blair C; Wang H; Gaggar A; Brainard DM; McPhail MJ; Bhagani S; Ahn MY; Sanyal AJ; Huhn G; Marty FM;
JAMA; 2020 Sep; 324(11):1048-1057. PubMed ID: 32821939
[TBL] [Abstract][Full Text] [Related]
17. Compassionate use of remdesivir in children with COVID-19.
Méndez-Echevarría A; Pérez-Martínez A; Gonzalez Del Valle L; Ara MF; Melendo S; Ruiz de Valbuena M; Vazquez-Martinez JL; Morales-Martínez A; Remesal A; Sándor-Bajusz KA; Cabañas F; Calvo C
Eur J Pediatr; 2021 Apr; 180(4):1317-1322. PubMed ID: 33200304
[TBL] [Abstract][Full Text] [Related]
18. Remdesivir for the Prevention of Invasive Mechanical Ventilation or Death in Coronavirus Disease 2019 (COVID-19): A Post Hoc Analysis of the Adaptive COVID-19 Treatment Trial-1 Cohort Data.
Paules CI; Gallagher SK; Rapaka RR; Davey RT; Doernberg SB; Grossberg R; Hynes NA; Ponce PO; Short WR; Voell J; Wang J; Yang OO; Wolfe CR; Lye DC; Dodd LE; Benson CA
Clin Infect Dis; 2022 Apr; 74(7):1260-1264. PubMed ID: 34379740
[TBL] [Abstract][Full Text] [Related]
19. Deconstructing the Treatment Effect of Remdesivir in the Adaptive Coronavirus Disease 2019 (COVID-19) Treatment Trial-1: Implications for Critical Care Resource Utilization.
Fintzi J; Bonnett T; Sweeney DA; Huprikar NA; Ganesan A; Frank MG; McLellan SLF; Dodd LE; Tebas P; Mehta AK
Clin Infect Dis; 2022 Jul; 74(12):2209-2217. PubMed ID: 34409989
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of remdesivir in hospitalized Covid-19 patients: Systematic review and meta-analysis including network meta-analysis.
Elsawah HK; Elsokary MA; Abdallah MS; ElShafie AH
Rev Med Virol; 2021 Jul; 31(4):e2187. PubMed ID: 33128490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
